From health coalitions calling for patient protection post-Brexit, to the MHRA campaigning for more reporting of medicine side-effects, and from the head of the UK medicines agency announcing he's to step down, to a scheme to support real-world testing of new products, here’s what’s hitting the headlines this week across the medical devices sector! Take a look -
Interested in Star’s innovative outsourcing and resourcing solutions?
Contact Head of Business Development, Ryan Wooller, at email@example.com, or get in touch on 07748 464 079.
On the hunt for a new role, or just curious?
Visit our candidate page, submit your CV to firstname.lastname@example.org, or give our offices a ring!
The head of Britain’s medicines watchdog is to step down in September 2019, handing over the reins to a yet to be appointed successor at a time of heightened regulatory concerns due to Brexit.
A UK coalition of pharma, NHS and biotech bodies says that Brexit negotiators have a responsibility to make patient safety and public health central to the Political Declaration for the future relationship between the UK and the EU.
This week, the Medicines and Healthcare products Regulatory Agency (MHRA) is running a campaign to raise awareness of reporting medicine side-effects.
A three-months trial scheme in Wigan has seen nearly 380 items of medical equipment returned for re-use or recycling, totalling 759kg.
Businesses can apply for a share of up to £1.5 million to support real-world testing of new medical devices, diagnostics and technologies in the NHS.